Skip to main content
NIBEC CO., LTD. logo

NIBEC CO., LTD. — Investor Relations & Filings

Ticker · 138610 ISIN · KR7138610001 KO Manufacturing
Open in API
Filings indexed 218 across all filing types
Latest filing 2019-04-29 Investor Presentation
Country KR South Korea
Listing KO 138610

About NIBEC CO., LTD.

https://nibec.co.kr/en/

NIBEC CO., LTD. is a biotechnology company specializing in the research, development, and commercialization of healthcare solutions centered on proprietary peptide technology. The company's core activities involve the manufacturing of tissue regenerative biomaterials, such as dental bone grafts and collagen-based products, as well as biomaterial-based medical devices. In addition to its focus on regenerative medicine, NIBEC develops and markets a range of dental care and cosmetic products. The company is also actively engaged in the research and development of novel peptide-based drugs and bio-fusion technologies to address various therapeutic needs.

Recent filings

Filing Released Lang Actions
투자설명서
Investor Presentation Classification · 95% confidence The document is a '투자설명서' (Investment Prospectus) for a capital increase (rights offering) by NIBEC. It contains detailed information regarding the offering, including the number of shares, subscription periods, payment dates, and extensive 'Risk Factors' (핵심투자위험) related to the company's business, financials, and market position. This document is a formal regulatory filing required for public offerings of securities, which falls under the category of a Prospectus/Offering Document. Given the provided categories, 'PSI' (Proxy Solicitation & Information Statement) is the closest fit for formal offering/information materials sent to shareholders, or alternatively, it is a regulatory filing. However, as it is a formal investment prospectus for a capital raise, it is classified as a Proxy Solicitation & Information Statement (PSI) in the context of regulatory disclosure materials.
2019-04-29 Korean
권리락(유상증자)
Share Issue/Capital Change Classification · 98% confidence The document is a short announcement regarding a 'rights off' (권리락) event due to a capital increase (유상증자) for the company NIBEC. It provides specific details such as the reference price and the effective date. This falls under the category of capital changes or share issues, specifically fitting the 'Share Issue/Capital Change' classification.
2019-04-29 Korean
유상증자1차발행가액결정
Capital/Financing Update Classification · 100% confidence The document is an official announcement regarding the determination of the '1st issuance price' for a capital increase (paid-in capital increase/rights offering) by the company RNL Bio (Naubeck). It details the calculation methodology, the number of shares, and the pricing formula for the capital raise. This falls under the category of capital and financing updates.
2019-04-26 Korean
[첨부추가]전환사채(해외전환사채포함)발행후만기전사채취득(제5회차)
Capital/Financing Update Classification · 95% confidence The document is a formal regulatory filing from a Korean company (NIBEC) regarding the acquisition of convertible bonds before maturity. It details the bond series, acquisition amount, reason (early redemption request), and method (off-market purchase). This falls under capital structure changes and financing updates, specifically related to debt instruments.
2019-04-17 Korean
주주명부폐쇄기간또는기준일설정
Share Issue/Capital Change Classification · 95% confidence The document is a short regulatory announcement regarding the suspension of share registration (shareholder register closure) for the purpose of a rights offering (capital increase). It does not contain the full financial report or the actual share issuance details, but rather serves as a formal notice of a corporate action. Given the nature of the announcement regarding capital structure changes and the regulatory context, it fits best under the 'Share Issue/Capital Change' category.
2019-04-03 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Financial Services Commission/Korea Exchange regarding a decision for a paid-in capital increase (유상증자결정). This is a formal regulatory filing detailing the terms of a capital raise, including share issuance, pricing, and subscription methods. It fits the 'Share Issue/Capital Change' category as it specifically details the company's decision to issue new shares.
2019-04-02 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.